Presented at the IASCLC 2020 North America Conference on Lung Cancer
![[Poster] Improving Care for Patients With Stage III/IV NSCLC: Learnings for Multidisciplinary Teams at IASCLC](https://cdn.sanity.io/images/gvduir9b/production/a42c11bb24c696c91d8e82dc8b1b8b99fabd808b-276x360.png?fit=crop&auto=format)
Presented at the IASCLC 2020 North America Conference on Lung Cancer, October 16 to October 17, 2020.
Authors
Ravi Salgia1; Leigh M. Boehmer2; Catherine Celestin3; Hong Yu3; David R. Spigel4
1Department of Medical Oncology and Therapeutics Research, City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA; 2Editorial Content & Strategy, Association of Cancer Care Centers, Rockville, MD, USA; 3Oncology Group, AstraZeneca, Gaithersburg, MD, USA; 4Lung Cancer Research Program, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA
Background
The Association of Cancer Care Centers (ACCC) has designed a quality metric for ideal NSCLC care, which has guided the development of a national survey to improve understanding of diagnosis and management of patients with stage III/IV NSCLC across different U.S.-based practice settings and to design and execute process improvement plans to address the identified barriers.
Download Supplement
Download Infographic
ASCO Abstract: What Defines Quality Lung Cancer Care?
June 12, 2020
